Device Trial Radar · NCT05597631
G-IVF and Sperm Parameters
Last checked: Nov 20, 2026Latest source record: Aug 30, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
118
Planned (sponsor's estimate)
Start
Oct 2023
Primary completion
Mar 2024
Study completion Apr 2024
Sponsor
- Lead sponsor
- VitrolifeNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 28, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Male only, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to investigate if adding a fixed volume of a physiological solution to a freshly produced sperm sample will affect sperm characteristics.
Conditions
- Infertility, Male
Interventions
G-IVF PLUSDevice
Experimental
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of progressive motile sperm (%)Time frame: 10 minutes of assessment will be used to count the motile sperm for each sample.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
IASO Maternity and Gynecology Clinic
Marousi, Greece
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.